Replimune Group, Inc. (REPL)

5.21 +0.05 (+0.97%) USD  |  NASDAQ  |  May 21, 16:00
5.33 +0.12 (+2.30%) After-Hours: 19:59
More

Replimune Group Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade